Heteroaryl amines as glycogen synthase kinase 3Beta inhibitors (GSK3 inhibitors)

Details for Australian Patent Application No. 2002363176 (hide)

Owner Janssen Pharmaceutica N.V.

Inventors Buijnsters, Peter Jacobus Johannes Antonius; Van Aken, Koen Jeanne Alfons; Janssen, Paul Adriaan Jan; De Jonge, Marc Rene; Love, Christopher John; Lewi, Paulus Joannes; Freyne, Eddy Jean Edgard; Koymans, Lucien Maria Henricus; Heeres, Jan; Embrechts, Werner Constant Johan; Vinkers, Hendrik Maarten; Diels, Gaston Stanislas Marcella; Willems, Marc

Agent Shelston IP

Pub. Number AU-B-2002363176

PCT Number PCT/EP02/12077

PCT Pub. Number WO2003/037891

Priority 01204196.8 01.11.01 EP

Filing date 29 October 2002

Wipo publication date 12 May 2003

Acceptance publication date 25 September 2008

International Classifications

C07D 403/12 (2006.01) Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

A61K 31/4406 (2006.01) - only substituted in position 3, e.g. zimeldine

A61K 31/501 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/506 (2006.01) - not condensed and containing further heterocyclic rings

A61K 31/5377 (2006.01)

A61P 3/10 (2006.01) Drugs for disorders of the metabolism

A61P 17/00 (2006.01) Drugs for dermatological disorders

A61P 21/04 (2006.01) Drugs for disorders of the muscular or neuromuscular system

A61P 25/00 (2006.01) Drugs for disorders of the nervous system

A61P 25/04 (2006.01) Drugs for disorders of the nervous system

A61P 25/16 (2006.01) Drugs for disorders of the nervous system

A61P 25/18 (2006.01) Drugs for disorders of the nervous system

A61P 25/24 (2006.01) Drugs for disorders of the nervous system

A61P 25/28 (2006.01) Drugs for disorders of the nervous system

A61P 29/00 (2006.01) Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents

A61P 31/18 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

A61P 35/00 (2006.01) Antineoplastic agents

A61P 35/02 (2006.01) Antineoplastic agents

C07D 213/74 (2006.01) Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members

C07D 239/42 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 239/48 (2006.01) Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings

C07D 401/04 (2006.01) Heterocyclic compounds containing two or more hetero rings

C07D 401/12 (2006.01) Heterocyclic compounds containing two or more hetero rings

Event Publications

5 June 2003 Complete Application Filed

  Priority application(s): 01204196.8 01.11.01 EP

10 July 2003 Application Open to Public Inspection

  Published as AU-B-2002363176

25 September 2008 Application Accepted

  Published as AU-B-2002363176

22 January 2009 Standard Patent Sealed

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2002363177-Aminobenzamide derivatives as glycogen synthase kinase 3Beta inhibitors

2002363175-MNK KINASE HOMOLOGOUS PROTEINS INVOLVED IN THE REGULATION OF ENERGY HOMEOSTASIS AND ORGANELLE METABOLISM